Venkataraman Balasubramanian

Array ( [id] => 14609633 [patent_doc_number] => 10357494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-23 [patent_title] => Combination therapy comprising varlitinib and an anticancer agent [patent_app_type] => utility [patent_app_number] => 15/757133 [patent_app_country] => US [patent_app_date] => 2016-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7776 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13603923 [patent_doc_number] => 20180353510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => Treatment of Biliary Duct Cancer [patent_app_type] => utility [patent_app_number] => 15/757166 [patent_app_country] => US [patent_app_date] => 2016-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13507565 [patent_doc_number] => 20180305325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => METHODS RESPECTIVELY FOR PRODUCING 2,4,6-TRIS (2-HYDROXY-3-METHYL-4-ALKOXYPHENYL)- 1,3,5- TRIAZINE COMPOUND AND 2,4,6-TRIS(2,4-DIHYDROXY-3-METHYLPHENYL)-1,3,5-TRIAZINE [patent_app_type] => utility [patent_app_number] => 15/758807 [patent_app_country] => US [patent_app_date] => 2016-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11350182 [patent_doc_number] => 20160368921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'SUBSTITUTED POLYCYCLIC CARBAMOLYPYRIDONE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 15/252791 [patent_app_country] => US [patent_app_date] => 2016-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 135878 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15252791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11382844 [patent_doc_number] => 20170008899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'BTK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/250978 [patent_app_country] => US [patent_app_date] => 2016-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 106813 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15250978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471161 [patent_doc_number] => 20170057943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'HYDROXYTRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/237763 [patent_app_country] => US [patent_app_date] => 2016-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41893 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15237763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16368992 [patent_doc_number] => 10800732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-13 [patent_title] => Substituted malonamides and their use as antibacterial drugs [patent_app_type] => utility [patent_app_number] => 15/752260 [patent_app_country] => US [patent_app_date] => 2016-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8385 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15752260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11443144 [patent_doc_number] => 20170044164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'BICYCLIC FUSED PYRIMIDINE COMPOUNDS AS TAM INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/234690 [patent_app_country] => US [patent_app_date] => 2016-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38302 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15234690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11657180 [patent_doc_number] => 09670166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity' [patent_app_type] => utility [patent_app_number] => 15/229160 [patent_app_country] => US [patent_app_date] => 2016-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41192 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15229160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11880704 [patent_doc_number] => 09751863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-05 [patent_title] => 'Therapeutically active compounds and their methods of use' [patent_app_type] => utility [patent_app_number] => 15/229011 [patent_app_country] => US [patent_app_date] => 2016-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9438 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15229011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11294026 [patent_doc_number] => 20160343959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'Organometallic Iridium Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device' [patent_app_type] => utility [patent_app_number] => 15/227441 [patent_app_country] => US [patent_app_date] => 2016-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22622 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15227441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13311209 [patent_doc_number] => 20180207141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => 3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/749606 [patent_app_country] => US [patent_app_date] => 2016-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15132691 [patent_doc_number] => 10479792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Compounds [patent_app_type] => utility [patent_app_number] => 15/750896 [patent_app_country] => US [patent_app_date] => 2016-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27114 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11270426 [patent_doc_number] => 20160332973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/221156 [patent_app_country] => US [patent_app_date] => 2016-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33836 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15221156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12509136 [patent_doc_number] => 10000496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => Compositions useful for treating disorders related to kit and PDGFR [patent_app_type] => utility [patent_app_number] => 15/217503 [patent_app_country] => US [patent_app_date] => 2016-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16872 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 505 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15217503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11706191 [patent_doc_number] => 20170174691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'Protein Kinase Conjugates and Inhibitors' [patent_app_type] => utility [patent_app_number] => 15/213319 [patent_app_country] => US [patent_app_date] => 2016-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 42260 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15213319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13589791 [patent_doc_number] => 20180346444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => EGFR KINASE INHIBITOR AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/763156 [patent_app_country] => US [patent_app_date] => 2016-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10621 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11363948 [patent_doc_number] => 20170001929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'COMPLEXES OF 1-METHYLCYCLOPROPENE WITH METAL COORDINATION POLYMER NETWORKS' [patent_app_type] => utility [patent_app_number] => 15/206707 [patent_app_country] => US [patent_app_date] => 2016-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10363 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15206707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13314061 [patent_doc_number] => 20180208567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => PROCESS FOR MAKING HYDROXYETHYL PIPERAZINE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 15/743772 [patent_app_country] => US [patent_app_date] => 2016-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2698 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15743772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12884944 [patent_doc_number] => 20180186823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/737073 [patent_app_country] => US [patent_app_date] => 2016-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33407 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737073 [rel_patent_id] =>[rel_patent_doc_number] =>)